Vaccination against Bluetongue serotype 3 has started in Spain with Syvazul BTV3
Press release
León, Thursday 3rd October 2024
Laboratorios Syva announces that the first doses of its vaccine Syvazul BTV3 already arrived in Andalusia and Extremadura, allowing to start promptly the vaccination programme against this new serotype.
In September 2023, Bluetongue serotype 3 was detected for the first time in the Netherlands, spreading rapidly to neighbouring countries.
In September 2024, outbreaks were detected in the south of Portugal, very close to the border with Spain, which set in motion the protocols for the prevention and control of Bluetongue by the MAPA (Spanish Ministry of Agriculture, Fisheries and Food.) and the Autonomous Communities.
After the MAPA urged the need for vaccines against serotype 3, on 25 September 2024, the AEMPS gave its approval, for the emergency use of Syvazul BTV3 in accordance with Art. 110 (2) of the (EU) 2019/6 Regulation.
Ultimately, on 30 September, the first outbreaks were confirmed in Spain, in the provinces of Huelva and Badajoz.
Laboratorios Syva supplied the first doses to MAPA, with Syvazul BTV 3 being the first vaccine applied immediately for the control of serotype 3 in Spain on October 2, 2024.
Over the next few days, the Autonomous Communities of Castilla y León, Extremadura and Andalusia will receive more doses of Syvazul BTV3 to be able to continue the vaccination programme.
Bluetongue serotype 3 has been particularly aggressive in both sheep and cattle, causing high mortality in sheep and severe clinical signs in cattle.
Vaccination is the most effective method to control Bluetongue.
Syvazul BTV3 is indicated for active immunisation in sheep and cattle, thereby reducing clinical symptoms and viraemia caused by Bluetongue serotype 3.
Syvazul BTV3 is a vaccine against Bluetongue serotype 3 authorised for emergency use in the Netherlands, Belgium, Germany, Austria and now in Spain in accordance with Art. 110 (2) of Regulation (EU) 2019/6. Syvazul BTV3 is also approved for emergency use in the UK. Since the first authorisation, more than 3 million doses have already been administered in these countries.
More information on the disease and on the vaccine on this web page
Bluetongue Infographic: don’t underestimate the consequences!
Video over Bluetongue
Downloads
You may also be interested in
20 May, 2026
Syvac® EH Marker is now marketed under the name ORBYK EHD
This name change supports Laboratorios Syva’s positioning strategy within the orbivirus sector and helps reinforce the consistency and identity of its portfolio of products and solutions aimed at preventing vector-borne diseases in ruminants.
13 May, 2026
Syva celebrated its first edition of the Sheep Dialogues in Castilla-La Mancha.
Desde Syva se ha querido destacar la excelente acogida que ha tenido esta primera edición, así como el alto nivel técnico y profesional de las ponencias desarrolladas a lo largo del encuentro. Los debates generados durante la jornada han evidenciado el firme compromiso del sector con la innovación, la formación continua y la incorporación de soluciones que permitan avanzar...
30 March, 2026
Biosecurity, prevention and bluetongue: key factors for the present and future of the sector
On 26 March, Syva attended the II International Conference on “Biosecurity and prevention in livestock herds – a tool for good times and bad times”, organised as part of the Międzynarodowa Konferencja in Poland.
Media tool kit
We provide users, particularly journalists and the press, with a series of graphic documents, photographs and videos. We offer the free use of these documents under certain conditions
Journalist and Press Contact
Are you a journalist, part of the press or the media? Do you want to get information on our activities, validate your sources in a professional manner, obtain validated photographic material or request an interview?
